Literature DB >> 2116476

Combined effects of tumor necrosis factor-alpha, prostaglandin E2, and corticosterone on induced Ia expression on murine macrophages.

T Zimmer1, P P Jones.   

Abstract

Ia expression is an important marker of macrophage functional capacity. IFN-gamma induces Ia expression on perhaps all murine macrophages, whereas IL-4, granulocyte-macrophage CSF, and CSF-1 induce Ia on restricted sets of macrophages. Inhibitors of expression include PGE2, glucocorticoids, and IFN-beta. TNF has been found to augment Ia expression on several macrophage lineage cell lines but to inhibit expression on murine peritoneal macrophages. Our study shows that TNF can have opposite effects on Ia expression (induced by IFN-gamma) on thioglycollate-elicited peritoneal macrophages, depending on the length of time cells are treated and on the presence of other modulators. In particular, TNF augmented early expression induced by IFN-gamma but inhibited later expression. And although TNF synergized with PGE2 to markedly inhibit Ia induction on these cells, it partially antagonized the inhibition by corticosterone and IFN-beta. TNF and PGE2 also synergized to inhibit Ia expression induced on bone marrow-derived and splenic macrophages by either IFN-gamma or IL-4. In contrast to their effect on Ia expression, TNF and PGE2 had opposite effects on expression of gamma 2a FcR in macrophages. TNF blocked the increase in FcR expression due to any combination of PGE2, IFN-gamma, and IFN-beta. However, TNF and PGE2 both increased expression of gamma 2a FcR on WEHI-3 cells. If the different effects of TNF reflect the differentiation states of macrophages, its effects on Ia and FcR expression may vary with the progression of an immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116476

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  MHC class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases.

Authors:  C O Jacob; G D Lewis; H O McDevitt
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Control of major histocompatibility complex class II expression on human monocytes by interleukin-4: regulatory effect of lipopolysaccharide.

Authors:  P H Hart; C S Bonder; C A Jones; J J Finlay-Jones
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

Review 3.  Current concepts in DRA gene regulation.

Authors:  J P Ting
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

Authors:  D Ashany; X Song; E Lacy; J Nikolic-Zugic; S M Friedman; K B Elkon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Regulation of Fc receptor and major histocompatibility complex antigen expression on isolated rat microglia by tumour necrosis factor, interleukin-1 and lipopolysaccharide: effects on interferon-gamma induced activation.

Authors:  A J Loughlin; M N Woodroofe; M L Cuzner
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

6.  Pulmonary surfactant inhibits activation of human monocytes by recombinant interferon-gamma.

Authors:  M F Geertsma; W L Teeuw; P H Nibbering; R van Furth
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

7.  Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.

Authors:  S Hasegawa; G Becker; H Nagano; P Libby; R N Mitchell
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Activation of monocyte effector genes and STAT family transcription factors by inflammatory synovial fluid is independent of interferon gamma.

Authors:  T K Sengupta; A Chen; Z Zhong; J E Darnell; L B Ivashkiv
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

9.  Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements.

Authors:  L B Ivashkiv; L H Glimcher
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein.

Authors:  A Celada; S McKercher; R A Maki
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.